AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceHealth Care
Vascular ResistanceHypertensionHypertension, PulmonaryBlood PressureHemodynamicsDrug ResistancePulmonary CirculationHypertension, PortalHypertension, RenalCardiac OutputDrug Resistance, MicrobialDrug Resistance, BacterialAntihypertensive AgentsPulmonary ArteryRegional Blood FlowHypertension, RenovascularHeart RateDrug Resistance, NeoplasmRenal CirculationVasoconstrictionHypertension, MalignantForearmVasodilator AgentsDrug Resistance, MultipleDogsDisease ResistanceKidneyVasodilationNitric OxidePulmonary Wedge PressureDrug Resistance, ViralDrug Resistance, Multiple, BacterialReninHypertension, Pregnancy-InducedTime FactorsRats, Inbred SHRNorepinephrineAngiotensin IIBlood Flow VelocitySympathetic Nervous SystemAnoxiaAnti-Bacterial AgentsVasoconstrictor AgentsRisk FactorsDose-Response Relationship, DrugMicrobial Sensitivity TestsRats, Inbred WKYBlood CirculationNitroprussideLungSplanchnic CirculationVasomotor SystemRats, Sprague-DawleyArteriesBlood Pressure DeterminationEpoprostenolPressoreceptorsOcular HypertensionPerfusionRenal ArteryDisease Models, AnimalArterial PressureEndothelin-1MutationReflexPregnancy Complications, CardiovascularCoronary CirculationMonocrotalineCardiovascular SystemRenin-Angiotensin SystemNG-Nitroarginine Methyl EsterTetracycline ResistanceReceptors, EndothelinCardiac CatheterizationHypertrophy, Right VentricularOxygenSodium Chloride, DietaryHypotensionTreatment OutcomeSulfonesAirway ResistanceBlood VolumePlethysmographyDesoxycorticosteroneProspective StudiesLower Body Negative PressureCaptoprilNitric Oxide SynthaseAldosteronePregnancyPrevalenceIntracranial HypertensionReceptor, Endothelin APersistent Fetal Circulation SyndromeCentral Venous PressurePlant DiseasesIloprostObesityChronic DiseasePenicillin Resistance
Portal hypertensionRenalRight ventricularIdiopathicIncrease in pulmonaryPathophysiologyCardiac output and peripheral vascular rArterial hypertensionChronicComplicationsTreatment of HypertensionEssential HypertensionPrecapillary pulmonary hypertensionDiastolicForm of pulmonary hypertensionPresence of pulmonaryClinicalPatientsSecondary hypertensionIncreased vascular toneHemodynamicNitric OxideDysfunctionPathogenesisPrevalence of hypertensionPulmonary artery pressurePediatricAtherosclerosisChanges in vascularDiseasesSymptomsHyperlipidemiaLungAntihypertensiveImpairmentClassificationInducesAbstractVasoconstrictionPrimaryDiseaseDiabetesPPHNBlood
Portal hypertension13
  • The most common cause of portal hypertension is cirrhosis. (medscape.com)
  • The images below depict esophageal varices, which are responsible for the main complication of portal hypertension, upper gastrointestinal (GI) hemorrhage. (medscape.com)
  • In general, PPH is diagnosed 4-7 years after the patient is diagnosed with portal hypertension and in roughly 65% of cases, the diagnosis is actually made at the time of invasive hemodynamic monitoring following anesthesia induction prior to liver transplantation. (wikipedia.org)
  • In portal hypertension, blood will shunt from portal to systemic circulation, bypassing the liver. (wikipedia.org)
  • Inflammation and oxidative stress play a key role in the pathophysiology of advanced chronic liver disease (ACLD) and portal hypertension (PH). (mdpi.com)
  • In liver cirrhosis, portal hypertension is a consequence of enhanced intrahepatic vascular resistance and portal blood flow. (karger.com)
  • Baveno VI Faculty: Expanding consensus in portal hypertension - report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. (karger.com)
  • Rodríguez-Vilarrupla A, Fernández M, Bosch J, García-Pagán JC: Current concepts on the pathophysiology of portal hypertension. (karger.com)
  • Hu LS, George J, Wang JH: Current concepts on the role of nitric oxide in portal hypertension. (karger.com)
  • NASH is comparable to alcoholic cirrhosis/hepatitis, as it can follow the same sequelae of complications (portal hypertension [HTN], esophageal varices, increased bleeding times, decreased albumin, causing ascites, fluid shifts, malnutrition), but the risk factors for these diseases are different. (nursingcenter.com)
  • Common signs and symptoms may stem from decreased hepatic synthetic function (eg, coagulopathy), portal hypertension (eg, variceal bleeding), or decreased detoxification capabilities of the liver (eg, hepatic encephalopathy). (medscape.com)
  • Portal hypertension can have prehepatic, intrahepatic, or posthepatic causes. (medscape.com)
  • Paracentesis is essential in determining whether ascites is caused by portal hypertension or by another process. (medscape.com)
Renal6
  • Compared with patients meeting the traditional hemodynamic definition of PAH, patients with a PCWP of 16 to 18 mm Hg were older, more obese, had a lower 6-min walk distance, and had a higher incidence of systemic hypertension, sleep apnea, renal insufficiency, and diabetes. (nih.gov)
  • This article is a review of exciting, recently generated genetic, biochemical and clinical data from studies that have examined the importance of the tissue kallikrein-kinin system in protection from hypertension, vascular remodeling and renal fibrosis. (nature.com)
  • Development of novel therapeutic approaches to bolster kinin activity in the vascular wall and in specific compartments in the kidney might be a highly effective strategy for the treatment of hypertension and its complications, including cardiac hypertrophy and renal failure. (nature.com)
  • At least one or more of the mechanisms involved in BP regulation, such as vascular, neural, renal, and hormonal mechanisms, contribute to development of primary hypertension. (mhmedical.com)
  • The risk is increased for hypertension is Cerebrovascular accident (CVAs or strokes) Myocardial infarction (heart attack) Hypertensive cardiomyopathy ( heart failure due to chronically high blood pressure) Hypertensive retinopathy - damage to the retina and Hypertensive nephropathy - chronic renal failure due to chronically high blood pressure. (health-care-articles.info)
  • The first group of hypertension and renal disease was managed by Jan Brod, the group of coronary artery diseases was managed by Vilém Ganz, the group of atherosclerosis by Tibor Zemplényi, the group of circulatory regulation by Zdeněk Fejfar, and the group of higher nervous activity by Valtr Ehrlich. (ikem.cz)
Right ventricular9
  • Scholars@Duke publication: Right ventricular failure--insights provided by a new model of chronic pulmonary hypertension. (duke.edu)
  • This study was designed to examine the effects of both nitric oxide and milrinone on pulmonary hemodynamics and right ventricular function using a newly established model of monocrotaline pyrrole-induced chronic pulmonary hypertension. (duke.edu)
  • Both nitric oxide and milrinone resulted in significant improvements in pulmonary vascular resistance, pulmonary blood flow, and right ventricular contractility. (duke.edu)
  • This study demonstrates the well-known clinical effects of nitric oxide and milrinone in improving pulmonary hypertension, which were also associated with an increase in pulmonary blood flow, transpulmonary efficiency, and right ventricular hydraulic power in the setting of monocrotaline pyrrole-induced chronic pulmonary hypertension. (duke.edu)
  • Severe pulmonary hypertension leads to right ventricular overload and failure. (msdmanuals.com)
  • OBJECTIVES The REPAIR (Right vEntricular remodeling in Pulmonary ArterIal hypeRtension) study evaluated the effect of macitentan on right ventricular (RV) and hemodynamic outcomes in patients with pulmonary arterial hypertension (PAH), using cardiac magnetic resonance (CMR) and right heart catheterization (RHC). (uni-koeln.de)
  • Background Blood flow is closely related to function, but currently, the relationship of right ventricular (RV) blood flow components with RV function and hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH) remains unclear. (researchgate.net)
  • Chronic cor pulmonale is associated with pulmonary hypertension and right ventricular hypertrophy. (cdc.gov)
  • Pulmonary hypertension (PH) is a fatal disorder characterized by an increase in pulmonary vascular resistance, which leads to right ventricular failure. (jrheum.org)
Idiopathic3
  • Idiopathic persistent pulmonary hypertension of the newborn can present without signs of acute perinatal distress. (medscape.com)
  • Pulmonary hypertension in children is most commonly idiopathic or hereditary PAH or caused by congenital heart disease. (bjcardio.co.uk)
  • PAH is a complication of various connective tissue diseases (CTD), including scleroderma (affecting roughly 10% of patients), systemic lupus erythematosus (SLE), mixed CTD, dermatomyositis, Sjogren's syndrome and rheumatoid arthritis.7 Compared with idiopathic pulmonary hypertension patients, these patients are predominantly female, are older at the time of diagnosis of PAH and have shorter survival (the unadjusted risk of death is three times higher than in IPAH). (bjcardio.co.uk)
Increase in pulmonary1
  • Complications of the disease are difficult to treat when the increase in pulmonary vascular resistance is due to blood vessel destruction as in cases of silicosis. (cdc.gov)
Pathophysiology2
  • The pathophysiology behind hypertension in the elderly is a complex process that is not entirely understood, but it is attributed to an increase in peripheral vascular resistance caused by decreased elasticity and increased stiffness due to smooth muscle hypertrophy in arterial walls. (uspharmacist.com)
  • Pathophysiology of primary hypertension is complex and heterogeneous. (mhmedical.com)
Cardiac output and peripheral vascular r2
Arterial hypertension18
  • 3 Wood units is a criterion of the haemodynamic definition of pulmonary arterial hypertension (PAH). (ersjournals.com)
  • Pulmonary arterial hypertension (PAH) is a haemodynamic consequence of obstructive remodelling of the small pulmonary arteries and patients can progress to right-heart failure and death [ 1 ]. (ersjournals.com)
  • The Registry to EValuate Early And Long-term pulmonary arterial hypertension disease management (REVEAL Registry) was established to provide updated characteristics of patients with pulmonary arterial hypertension (PAH) and to improve diagnosis, treatment, and management. (nih.gov)
  • In contrast to pulmonary arterial hypertension, PH-LHD is characterised by an elevated pulmonary artery wedge pressure (postcapillary pulmonary hypertension) without or with an additional precapillary component (isolated postcapillary vs combined postcapillary and precapillary pulmonary hypertension). (smw.ch)
  • There is currently no established indication for pulmonary arterial hypertension-specific therapies in PH-LHD, and specific therapies may even cause harm in patients with PH-LHD. (smw.ch)
  • Maeder MT, Kleiner R, Weilenmann D. Severely worsening dyspnea after initiation of macitentan therapy for pulmonary arterial hypertension. (smw.ch)
  • Patients with pulmonary arterial hypertension (PAH, WHO Group 1) taking this combination showed hemodynamic improvement, as well as improvements in functional parameters and risk profiles. (jnj.com)
  • Pulmonary arterial hypertension (PAH) is a progressive disease characterized by lung endothelial cell dysfunction and vascular remodeling. (surrey.ac.uk)
  • In the first group (pulmonary arterial hypertension [PAH]), the primary disorder affects the small pulmonary arterioles. (msdmanuals.com)
  • The pathogenesis of arterial hypertension often involves a rise in systemic vascular resistance (vasoconstriction and vascular remodeling) and impairment of salt excretion in the kidney (inappropriate salt retention despite elevated blood pressure). (nature.com)
  • Precapillary PH was found in 64 patients (5%), of whom 42 had pulmonary arterial hypertension (PAH) and 22 had PH secondary to interstitial lung disease (ILD). (jrheum.org)
  • The Dana Point classification distinguishes pulmonary arterial hypertension (PAH) from PH secondary to other morbid entities 1 . (jrheum.org)
  • If the high blood pressure in the lungs is due to narrowing of the pulmonary arteries leading to increased pulmonary vascular resistance, it is known as pulmonary arterial hypertension (PAH). (scleroderma.org)
  • Over the past decade, awareness among the medical profession of pulmonary arterial hypertension (PAH) being a treatable disease has increased. (ersjournals.com)
  • The management of patients with pulmonary arterial hypertension (PAH) has improved rapidly over the past decade with the introduction of PAH-specific therapies developed following increasing research into and enhanced knowledge of the pathogenesis of the disease. (ersjournals.com)
  • These include children who present with pulmonary arterial hypertension (PAH), and those with underlying connective tissue disease or congenital heart defects. (bjcardio.co.uk)
  • Literature review: Characterized by a fast, intense, and improper increase in blood pressure, hypertensive crisis is one of the complications of arterial hypertension. (bvsalud.org)
  • A transesophageal echocardiogram was performed, showing an interatrial tipo ostium ostium secundum atrial septal defect and severe pulmonary arterial hypertension with a right-left shunt. (bvsalud.org)
Chronic3
Complications1
Treatment of Hypertension2
  • Doxazosin tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. (nih.gov)
  • According to the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7), the SBP should be the primary target for diagnosis and treatment of hypertension in the elderly ( TABLE 1 ). (uspharmacist.com)
Essential Hypertension4
Precapillary pulmonary hypertension1
  • Data is lacking on the natural history, response to therapy and survival of patients diagnosed with precapillary pulmonary hypertension (PH) with mild or borderline elevation of PVR. (ersjournals.com)
Diastolic5
  • Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. (nih.gov)
  • Stage 1 hypertension: systolic pressure of 140-159 mm Hg or diastolic pressure of 90-99 mm Hg. (mhmedical.com)
  • Stage 2 hypertension: systolic pressure of at least 160 mm Hg or diastolic pressure of at least 100 mm Hg. (mhmedical.com)
  • Hypertension has been arbitrarily defined as a systolic blood pressure above 140 mmHg or a diastolic blood pressure above 90 mmHg. (health-care-articles.info)
  • PCBs that exceeded 3.5 for both systolic and diastolic hypertension. (cdc.gov)
Form of pulmonary hypertension1
Presence of pulmonary1
  • In patients with left-sided heart disease, the presence of pulmonary hypertension is typically a marker of more advanced disease, more severe symptoms, and worse prognosis. (smw.ch)
Clinical6
  • Experimental and clinical evidence implicate an imbalance between endogenous vasoconstrictor and vasodilator systems in the development and maintenance of hypertension. (nature.com)
  • His outpatient clinical time is split between three clinics (1) the lung transplantation clinic, where he sees patients with advanced lung disease before and after transplantation, (2) the pulmonary hypertension clinic, where he sees patients with pulmonary hypertension and pulmonary emboli, and (3) the general pulmonary clinic, where he supervises the excellent care provided by fellows in the UCSF Pulmonary and Critical Care Fellowship Program. (ucsf.edu)
  • A level for high blood pressure must be agreed upon in clinical practice for screening patients with hypertension and for instituting diagnostic evaluation and initiating therapy. (health-care-articles.info)
  • Published in The Journal of Clinical Endocrinology & Metabolism , hypertension during the second trimester was tied to a 49% increased risk for offspring overweight or obesity, while third-trimester hypertension was tied to 14% higher risk, according to Ju-Sheng Zheng, PhD, of Qingdao University in China, and colleagues. (medpagetoday.com)
  • Click here for the American Association of Clinical Endocrinologists' clinical practice guidelines for the medical care of hypertension and obesity . (medpagetoday.com)
  • Some patients belong to clinical group 1 of the pulmonary hypertension classification but their underlying conditions are different, and they require a different management strategy. (bjcardio.co.uk)
Patients17
  • Once patients are symptomatic, they present with right heart dysfunction secondary to pulmonary hypertension and its consequent dyspnea, fatigue, chest pain and syncope. (wikipedia.org)
  • The mean duration between symptom onset and diagnostic catheterization was 2.8 years, and 1,008 (41.3%) patients were treated with more than one pulmonary vascular-targeted medication. (nih.gov)
  • Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. (smw.ch)
  • Following multidisciplinary diagnosis and treatment (MDT), we decided to first control hypertension to alleviate the acute and critical patients. (frontiersin.org)
  • Objectives To test the hypothesis that vascular abnormalities on high-resolution CT (HRCT) would be associated with echocardiographic changes and lung function abnormalities in patients with sickle cell disease (SCD) and the decline in lung function seen in SCD patients. (bmj.com)
  • Vascular abnormalities on high-resolution CT (HRCT) would be associated with echocardiographic changes and lung function abnormalities in patients with sickle cell disease (SCD) and with the decline in lung function seen in SCD patients. (bmj.com)
  • Alterations in pulmonary vascular volumes due to anaemia in SCD patients may be responsible for some of their lung function abnormalities and changes seen on HRCT and their decline in lung function. (bmj.com)
  • The OPTIMA (c O mbination thera P y of maci T entan and tadalaf I l in patients with newly diagnosed pul M onary A rterial Hypertension) study was a prospective, multicenter, single-arm, open-label, Phase IV trial evaluating the efficacy, safety, and tolerability of initial oral combination therapy with OPSUMIT and tadalafil in patients with newly diagnosed PAH. (jnj.com)
  • OPSUMIT, in combination with tadalafil, showed a 47% reduction of the primary endpoint of mean pulmonary vascular resistance (PVR) at week 16 compared with baseline in patients with PAH," said Olivier Sitbon, M.D., Ph.D., principal investigator and professor of respiratory medicine at Université Paris-Sud. (jnj.com)
  • Accordingly, therapy often requires more than one antihypertensive agent or approach to tackle hypertension in the majority of patients. (mhmedical.com)
  • These steps are highly effective in reducing blood pressure, although most patients with moderate or severe hypertension end up requiring indefinite drug therapy to bring their blood pressure down to a safe level. (health-care-articles.info)
  • To measure the prevalence of different types of pulmonary hypertension (PH) and to identify patients with systemic sclerosis (SSc) at highest risk in a multicenter European sample, with a metaanalysis of relevant studies. (jrheum.org)
  • Methotrexate, for instance, is one of the oldest systemic treatment agents and was thought to have new promises in reducing vascular diseases in patients with psoriasis, but the CIRT trial showed that low-dose methotrexate did not reduce adverse cardiovascular events in patients with established CVD. (cardiometabolichealth.org)
  • Elevated levels of TNF-α and soluble TNF-α receptors are found in the skin lesions of patients with severe psoriasis, which are likewise present the development of atherosclerosis, deterioration of heart function, and remodeling of the vascular endothelium. (cardiometabolichealth.org)
  • In fact, measurement of these two hormones plays a central role in the diagnosis of primary aldosteronism (PA) (which is a major cause of resistant hypertension) and in guiding clinicians in the management of essential hypertensive patients. (hospitalhealthcare.com)
  • Outcomes studies of antimicrobial drug resistance are and study patients infected with resistant bacteria (the notoriously hard to perform because of confounding vari- exposure of interest for cases), who are compared either to ables related to underlying coexisting conditions (1). (cdc.gov)
  • the corresponding susceptible bacteria, the impact of In the analysis comparing patients with SSI caused by acquiring a resistance determinant is measured. (cdc.gov)
Secondary hypertension2
Increased vascular tone2
  • The functional changes include increased contraction and/or decreased relaxation responses resulting in increased vascular tone [1, 2]. (jle.com)
  • Heredity could be a significant factor in increased vascular tone and hypertension. (custom-essay.org)
Hemodynamic1
  • The participants were asked to consume (daily at home) 300 mg of oral magnesium-oxide supplementation product for one month and to have their blood pressure and hemodynamic parameters (thoracic fluid content, stroke volume, stroke index, cardiac output, cardiac index, acceleration index, left cardiac work index and systemic vascular resistance index, heart rate) measured in the hospital before and after the intervention. (nih.gov)
Nitric Oxide1
Dysfunction4
  • More specifically, proinflammatory adipokines from visceral adipose tissue may initiate the development of insulin resistance, microvascular dysfunction, and endothelial dysfunction. (hindawi.com)
  • Insulin resistance and endothelial dysfunction have both been implicated in the pathogenesis of hypertension [ 3 - 7 ] and atherosclerosis [ 8 , 9 ]. (hindawi.com)
  • Microvascular dysfunction may affect both peripheral vascular resistance and insulin-mediated glucose disposal, thereby contributing to hypertension and insulin resistance, respectively [ 10 ]. (hindawi.com)
  • The study was designed to evaluate the role of inflammation markers in the development of insulin resistance, microvascular dysfunction, and endothelial dysfunction and eventually the progression to (pre)diabetes and (pre)hypertension. (hindawi.com)
Pathogenesis2
  • Accordingly, the objective of this study was to investigate whether or not evidence of early pathogenesis involving inflammation markers is present in healthy young adult individuals, without diabetes or hypertension. (hindawi.com)
  • associated with an increased risk of hospitalization for Multiple factors contribute to the pathogenesis of hyper- hypertension, after adjustment for age, race, and sex [11] . (cdc.gov)
Prevalence of hypertension2
  • Hypertension is the most frequent modifiable cardiovascular risk factor and a continuous relationship between blood pressure, cardio- and cerebrovascular fatal and non-fatal events has been extensively demonstrated.1 Overall, the prevalence of hypertension ranges between 30% and 45% in the general population, but increases steeply with ageing, thereby representing one of most important contributors to mortality and morbidity in Western countries. (hospitalhealthcare.com)
  • Objective To determine risk factors for elevated blood with prevalence of hypertension. (cdc.gov)
Pulmonary artery pressure1
Pediatric1
  • and Ian Adatia is a professor of pediatrics, director of the pediatric pulmonary hypertension service, and a cardiac intensivist in the pediatric cardiac critical care unit at Stollery Children's Hospital, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada. (medscape.com)
Atherosclerosis1
Changes in vascular2
  • in addition, the decline in lung function correlated with changes in vascular dimension. (bmj.com)
  • Hypertension is a complex and multifactorial disease and is associated with increased peripheral vascular resistance due to changes in vascular structure and function. (jle.com)
Diseases7
  • Pulmonary hypertension associated with left heart and lung diseases. (smw.ch)
  • Pulmonary hypertension due to left heart diseases. (smw.ch)
  • Prior to joining Surrey, her research centred around pulmonary hypertension and connective tissue diseases. (surrey.ac.uk)
  • 3 Hypertension puts the elderly at greater risk for developing several cardiovascular diseases (CVDs), ranging from myocardial infarction, angina, and cerebrovascular disease to peripheral artery disease and cardiac failure. (uspharmacist.com)
  • With the same purpose, it is necessary to use mass media on a broader basis as well as disseminate published for population booklets and popular brochures on measures of control and prevention of cardio-vascular diseases, strengthening resistance of people to external negative impact and strengthening of protective factors. (who.int)
  • Special attention will be paid to prevention of cardio-vascular diseases, reduction of micronutrient insufficiency, stabilization of infectious diseases incidence rate including TB, malaria, helminthiasis, brucellosis, restriction of dissemination of HIV/AIDS and immunization-sensitive infections. (who.int)
  • Later, the institute focused on research of valvular defects in connection with the rapid development of cardiosurgery, research of cor pulmonale and research of peripheral vascular diseases. (ikem.cz)
Symptoms2
Hyperlipidemia2
  • Metabolic syndrome is a combination of conditions that include insulin resistance/Type II diabetes, HTN, hyperlipidemia, and obesity. (nursingcenter.com)
  • They come together as a symbiotic relationship, such as obesity coupled with insulin resistance, and with these come HTN and hyperlipidemia. (nursingcenter.com)
Lung8
  • 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). (smw.ch)
  • Results The segmental A/B ratio was negatively correlated with FEV 1 , vital capacity (VC), forced expiratory flow between 25% and 75% of VC (FEF 25/75 ) and arterial oxygen saturation (SpO 2 ) and positively with the residual volume: total lung capacity ratio (RV:TLC) and respiratory system resistance (Rrs). (bmj.com)
  • Conclusions Abnormalities in pulmonary vascular volumes may explain some of the lung function abnormalities and the decline in lung function seen in adults with SCD. (bmj.com)
  • Nicholas Kolaitis specializes in pulmonary and critical care medicine, with a focus on lung transplantation and pulmonary hypertension. (ucsf.edu)
  • Additionally, he is active in the International Society for Heart and Lung Transplantation as part of the Advocacy Committee, and in the Pulmonary Hypertension Association, where he serves on the steering committee for the Pulmonary Hypertension Association Registry. (ucsf.edu)
  • Impaired lung function, pulmonary hypertension, and asthma are all associated with MetDys. (cdc.gov)
  • COV treatment did not affect lung vascular permeability. (cdc.gov)
  • MetDys is a risk factor for lung function impairment, pulmonary hypertension, and asthma. (cdc.gov)
Antihypertensive1
Impairment2
  • We identified articles for review primarily by conducting a Medline search using the subject headings dementia, mild cognitive impairment, Alzheimer's disease, vascular dementia, frontotemporal dementia, and Lewy body dementia . (cdc.gov)
  • Articles included in this review were primarily identified through a Medline search of the terms dementia, mild cognitive impairment, Alzheimer's disease, vascular dementia, frontotemporal dementia, Lewy body dementia, mental disorders, and stigma . (cdc.gov)
Classification1
  • Because the risk to an individual patient may correlate with the severity of hypertension, a classification system is essential for making decisions about aggressiveness of treatment or therapeutic interventions. (health-care-articles.info)
Induces1
Abstract1
Vasoconstriction1
Primary5
Disease3
  • Pulmonary hypertension associated with left-sided heart disease (PH-LHD) is the most common type of pulmonary hypertension. (smw.ch)
  • Persistent pulmonary hypertension of the newborn (PPHN) is a disease entity that describes a physiology in which there is persistence of increased pulmonary arterial pressure. (cochrane.org)
  • A similar diagnostic workup to pulmonary hypertension in adulthood is recommended by the ESC 2015 guidelines, even though some disease associations are rare and should be excluded before a definite diagnosis of IPAH is made. (bjcardio.co.uk)
Diabetes1
PPHN3
  • Persistent pulmonary hypertension of the newborn (PPHN) is defined as the failure of the normal circulatory transition that occurs after birth. (medscape.com)
  • Persistent pulmonary hypertension of the neonate (PPHN) is a life-threatening condition. (cochrane.org)
  • PPHN is characterised by failure to adapt to a functional postnatal circulation with a fall in pulmonary vascular resistance. (cochrane.org)
Blood11